Covid-19 Pharma Insights
![Iceni Diagnostics lab work3[56] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8735/download/Iceni%20Diagnostics%20lab%20work3%5B56%5D%20copy.jpg?cb=721e8ffb3ddfd1aa0d648b6943b50db1&w=640 "Iceni Diagnostics lab work3[56] copy.jpg")
Opinion: Pandemic preparedness
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups. Read more
25 May 2022
The MedTalk Podcast - How iiCON is driving innovation in the UK and beyond
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic. Read more
1 Feb 2022
The future of Covid-19 vaccinations
Ivor Campbell managing director of Snedden Campbell discusses the future of Covid-19 vaccination and why testing is crucial amidst falling antibody levels. Read more
30 Nov 2021
Why the UK is a leader for observational research
Professor Saad Shakir, director of the Drug Safety Research Unit looks at observational research in the UK and why it's one of the nation's core strengths. Read more
3 Nov 2021
The MedTalk Podcast - Understanding Covid-19 vaccines with the DSRU
In this episode of The MedTalk Podcast, EPM editor, Reece Armstrong speaks to Professor Saad Shakir, Director of the Drug Safety Research Unit about the organisation's work to monitor the safety of Covid-19 vaccines after they were approved for use. Read more
16 Aug 2021
How Covid-19 has changed pharma's approach to technology
How one company found itself in the right place at the right time to help the pharma industry operate throughout Covid-19. Read more
27 Jul 2021
![Iceni Diagnostics lab work3[56] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8735/download/Iceni%20Diagnostics%20lab%20work3%5B56%5D%20copy.jpg?cb=721e8ffb3ddfd1aa0d648b6943b50db1&w={width}&h={height} "Iceni Diagnostics lab work3[56] copy.jpg")
Shutterstock
Humanigen strikes agreement with PCI for UK commercialisation
Humanigen has entered into an agreement with PCI Pharma Services (PCI) to provide importation, release, and commercialisation services in the UK for lenzilumab. Read more
16 Jun 2022
Programme highlights ChargePoint's role in COVID-19 vaccine rollout
Specialist Merseyside manufacturing business, ChargePoint Technology, appears in an ITN production exploring its role in helping to bring the first COVID-19 vaccine to market. Read more
3 May 2022
An Italian matrix behind a Covid-19 antiviral
In recent weeks, two medicines have been given the green light by the authorities in the treatment of patients affected by Coronavirus. Read more
28 Mar 2022
Sponsored Content
Taking AI-led drug discovery to another level
Withers & Rogers gives an insight into the new ways that AI is helping to accelerate drug discovery and highlights the challenges that exist when bringing such innovations to market. Read more
29 Jun 2022
Q&A with Lonza: Support for biotech startups
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation. Read more
29 Jun 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
The new frontier of delivering personalised medicine in acute settings
Insights from David Budd, CEO of genedrive, on the advances in pharmacogenetic testing technology to maintain quality of care and treatment optimisation in acute medical settings. Read more
27 May 2022
![Screenshot 2022-05-26 at 11.27.06[35][52] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8758/download/Screenshot%202022-05-26%20at%2011.27.06%5B35%5D%5B52%5D%20copy.jpg?cb=7e80a6a13b0c23bb4b3d9e072702aa93&w=640 "Screenshot 2022-05-26 at 11.27.06[35][52] copy.jpg")
Printing for the pharmaceutical industry
Alan Ryan, managing director at Technoprint, explains the challenges that printing businesses face in supplying the pharmaceutical industry and the medicine needed to solve them. Read more
26 May 2022
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Case study: Pellet coating testing using GS pan equipment
In this study, organic solutions and aqueous dispersions of ethylcellulose (EC) were used to prepare a prolonged drug release dosage form consisting of a single dose of drug subdivided into many small units. Read more
26 May 2022
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Opinion: Pandemic preparedness
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups. Read more
25 May 2022
![Screenshot 2022-05-26 at 11.27.06[35][52] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8758/download/Screenshot%202022-05-26%20at%2011.27.06%5B35%5D%5B52%5D%20copy.jpg?cb=7e80a6a13b0c23bb4b3d9e072702aa93&w={width}&h={height} "Screenshot 2022-05-26 at 11.27.06[35][52] copy.jpg")
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
White Papers
Sponsored Content
Sponsored Content
Lonza - New Webinar: Solid Form Screening and Rapid Formulation Selection to Meet Demands of Accelerated Timelines
Compare formulation strategy advantages and disadvantages through case studies Read more
1 Jun 2022
Peter Huber Kältemaschinenbau GmbH
Peter Huber Kältemaschinenbau is the technology leader for high precision thermoregulation solutions in research and industry. Huber temperature control units operate worldwide in engineering, laboratory and technology. Read more
